Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split NEWS: $SONN Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock SplitPRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it will effect a 1-for-8 reverse stoc...
SONN - Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split